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Chapter 5 
 
IMAGING NEWLY SYNTHESIZED PROTEINS IN LIVING CELLS 
 
5.1 Abstract 
Proteins tagged with azide-containing amino acids or sugars can be selectively 
modified by alkyne-containing fluorophores in complex cellular environments.  Many of 
the azide-reactive coupling partners reported thus far are membrane impermeant and 
require a toxic copper catalyst, making the visualization of intracellular proteins in live 
cells difficult.  We have synthesized a series of fluorescent coumarin-cyclooctyne 
conjugates and tested their ability to label intracellular proteins tagged with the 
methionine analogue azidohomoalanine in Rat-1 fibroblasts. Confocal fluorescence 
micrographs showed that all four fluorophores labeled intracellular proteins; the non- and 
monofluorinated cyclooctyne dye-labeling was localized to the cytoplasm, while the 
more reactive difluorinated cyclooctyne dye showed both cytoplasmic and nuclear 
staining.  The increase in fluorescence over background ranged from 8- to 20-fold, as 
measured by flow cytometry using concentrations of 10 or 50 μM, depending on the dye.  
Staining with MitoTracker Red and propidium iodide indicated that cells remained viable 
during labeling and imaging. These coumarin-cyclooctyne conjugates provide a powerful 
new tool for visualizing protein dynamics inside living cells. 
 
 
Manuscript in preparation for submission by Beatty KE, Fisk JD, Baskin JM, Bertozzi CR and Tirrell DA, 
2008. 
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5.2 Introduction 
Fluorescent labeling of proteins allows the visualization of dynamic cellular 
processes.  Labeling is most often accomplished through the generation of chimeric 
proteins by fusing the protein of interest to a fluorescent protein, such as GFP.[1, 2]  This 
strategy has been employed successfully for imaging live cells.  However, the addition of 
a large (30 kDa) tag can cause unpredictable perturbations in the target protein’s 
localization and activity. An alternative approach involves the introduction of a short 
peptide tag to the protein of interest that recognizes a small molecule fluorescent 
probe.[3-5]  These methods are powerful tools for biological studies of pre-selected 
proteins, but suffer from the drawback of requiring genetic manipulation as their means 
of introduction.  This prevents their ready use in studies of global cellular processes, such 
as protein synthesis or post-translational modification.   
In the post-genomic era, a more complete understanding of biological systems 
will be attained through strategies that tag proteins based on their spatial, temporal, or 
chemical identity.  Cellular proteins can be specifically tagged with small, reactive 
metabolite analogues by co-opting the host’s metabolic machinery.  This strategy has 
been employed to tag proteins with ketone,[6-9] azide,[10-13] or alkyne[14-16] 
functionalities to enable selective, minimally invasive protein tagging in complex 
biological mixtures.  Glycosylated,[17-19] phosphorylated,[20] farnesylated,[21] and 
fatty-acylated[22, 23] proteins have been isolated after incorporation of reactive 
analogues.  These post-translational modifications are regulated dynamically, and 
metabolic tagging has enabled proteome-level analyses that were not accessible by 
genetic manipulation.   
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Similarly, reactive amino acid analogues can be incorporated directly into 
proteins by using the cell’s translational machinery, enabling the selective modification 
of newly synthesized proteins.[24-28]  The azide- and alkyne-containing methionine 
(Met) analogues azidohomoalanine (Aha) and homopropargylglycine (Hpg) have been 
used to both visualize and identify a defined subset of the proteome.[29, 30] The use of 
these reactive analogues is reminiscent of conventional pulse-labeling with radioactive 
amino acids. In the present application, the endogenous cellular machinery places the 
reactive Met surrogates, rather than radioactive derivatives, at sites normally occupied by 
Met within proteins.  Proteins containing Aha and Hpg can then be reacted with azide- or 
alkyne-containing ligation partners using the highly efficient and selective copper-
catalyzed azide-alkyne ligation.[31, 32]  While this reaction has been used successfully 
for labeling purified proteins, complex cellular extracts, and fixed cells, the toxicity of 
copper makes this method incompatible with living cells[33, 34].  In contrast, the 
Staudinger ligation[11, 35] and the strain-promoted azide-alkyne ligation[33, 36-38] are 
compatible with living cells.  In this chapter, we describe the use of a strain-promoted 
ligation to label newly synthesized proteins with a set of coumarin-cyclooctynes. 
 
5.3 Results and Discussion 
We hypothesized that the more biologically compatible strain-promoted azide-
alkyne ligation reaction could be used to dye label Aha-containing proteins inside 
healthy, living cells.  The biocompatible ligation of cyclooctynes to azidosugars has been 
explored previously[33].  Further investigation demonstrated that the reactivity of the 
cyclooctyne could be improved by the addition of one or two fluorine atoms adjacent to 
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the alkyne[36, 38].  The improved reactivity of the fluorinated cyclooctynes enables rapid 
and sensitive labeling of cell surface azides for dynamic cell imaging and has been used 
to monitor glycan trafficking[36].  We anticipated that the conjugation of coumarin, a 
small, membrane-permeant fluorophore, to a cyclooctyne moiety would result in a 
molecule that could both be taken up by live cells and enable ligation to azides displayed 
on newly synthesized proteins.  Commercially available dimethylaminocoumarin 
(DMAC) was conjugated to various differentially-activated cyclooctyne acids via a short 
linker segment using standard coupling chemistry to give the coumarin-cyclooctyne 
conjugates 1-4 (Scheme 5.1).  The linker segment was included to improve the solubility 
of the dye and to increase the distance between the dye and its protein target, which may 
can improve fluorescence signal[39].   
These reactive coumarin-cyclooctynes were assessed for their ability to label 
newly synthesized proteins inside a mammalian Rat-1 fibroblast cell line using confocal 
fluorescence microscopy (Figures 5.1 and 5.2).  Cells were treated for 4 h with either 1 
mM Aha, 1 mM Met, or 1 mM Aha pre-treated with the protein synthesis inhibitor 
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Scheme 5.1.  Structure of Met, Aha, and the coumarin-cyclooctynes. 
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Figure 5.1.  Fluorescence labeling of proteins in Rat-1 Fibroblasts.  Confocal fluorescence imaging of 
fibroblasts grown for 4 h in media containing 1 mM Met (top row), 1 mM Aha pre-treated with the protein 
synthesis inhibitor anisomycin (aniso; second row), or 1 mM Aha (bottom two rows). After the pulse, cells 
were dye-labeled for 10 min with 50 μM 1 (column 1), 50 μM 2 (column 2), 10 μM 3 (column 3), or 50 
μM 4 (column 4).  Cells were counterstained with MitoTracker Red before imaging.  The images for each 
dye (1, 2, 3, or 4) were acquired using identical conditions to capture either coumarin or MitoTracker Red 
fluorescence.  Images of the mitochondria for cells pulsed with Aha are included to help distinguish 
individual cells as well as the cytoplasmic space [(Mito(Aha)]. The scale bar represents 20 μm.  
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Figure 5.2.  Projections of coumarin fluorescence from labeled proteins in Rat-1 Fibroblasts.  The 
coumarin projections correspond to the single slice coumarin images shown in Figure 5.1.  Single slice 
images of the mitochondria are included to distinguish individual cells and the cytoplasmic space and to 
ensure correct mitochondrial morphology.  The scale bar represents 20 μm.   
 
 
 
anisomycin ([Aha + aniso]).  The [Aha + aniso] control was included as a means to assess 
the contribution of free Aha to overall fluorescence signal in the cells. After the 4 h pulse, 
cells were washed and incubated with one of the dye conjugates for 10 min at 37 °C.  
Following incubation, the cells were washed again and treated with MitoTracker Red 
(Invitrogen), a membrane-permeant dye that localizes to functional mitochondria.  The 
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MitoTracker Red counterstain aids in delineating individual cells, distinguishing the 
cytoplasmic space from the nucleus, and assessing mitochondrial morphology as a 
measure of cell health. After counterstaining, cells were washed a final time and 
examined using confocal microscopy.  Images were captured using identical conditions 
for cells exposed to Aha, [Aha + aniso], or Met.  Substantial fluorescent labeling of cells 
was observed after 10 min of treatment with 1-4. The fluorescence of cells treated with 
Aha alone was much brighter than that of cells treated with either Met or [Aha + aniso], 
indicating that the observed labeling is specific to Aha and that most of the coumarin-
labeled Aha is protein associated.  
Unexpectedly, the fluorescence images revealed a distinction in the cellular 
localization of the dye conjugates.  Fluorescence in Aha-treated cells was bright in the 
cytoplasm and dim in the nucleus for 1 and 2, while the interior of cells labeled with 3 
appeared more uniformly fluorescent (Figures 5.1 and 5.2).  The molecular structure of 3 
differs from the other dye conjugates in two distinct ways: 3 is more highly fluorinated 
than either 1 or 2, and the linker segment in 3 is shorter and lacks the benzene ring 
contained in 1 and 2.  We sought to understand what feature of 3 was responsible for the 
difference in intracellular localization by synthesizing a dye conjugate with a reduced 
linker length (4, Scheme 5.1).  Dye conjugate 4 exhibited dim nuclear staining similar to 
that observed for 1 and 2, and we concluded that the nuclear staining for 3 can be 
attributed to the additional fluorination, either through the improved reactivity that this 
imparts to the conjugate or through a less well-defined change in the hydrophobic 
character of the dye.[36] 
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We utilized flow cytometry to determine a set of optimal conditions for labeling 
newly synthesized proteins as a function of the coumarin-cyclooctyne concentration, the 
reactive amino acid pulse length, and fluorophore-labeling time. Cells were pulse-labeled 
for 4 h with Aha or Met before treatment with each of the conjugates 1-4 for 10 min over 
a range of concentrations between 0.5 to 50 μM of each dye (Figure 5.3).  The mean 
coumarin fluorescence increased with increasing dye concentration for all four dyes.  The 
fluorescence enhancement, defined as the mean fluorescence for Aha-treated cells 
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Figure 5.3.  Flow cytometric analysis of coumarin fluorescence as a function of dye-concentration for cells 
pulse-labeled 4 h with Aha or Met.  A.  Mean fluorescence enhancement for cells dye-labeled for 10 min (1 
grey bars, 2 hashed bars, 3 black bars, and 4 white bars).  B.  Mean fluorescence values for cells dye-
labeled 10 min with either 10 μM or 50 μM of each dye.  For each sample, 20,000 events were collected. 
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divided by the mean fluorescence for Met-treated cells, increased with increasing 
concentration for 1, 2, and 4.  In contrast, the optimal enhancement for cells treated with 
3 was observed not at the highest dye concentration, but at 10 μM 3.   
We hypothesized that the high cellular labeling for cells pulse-labeled with Met 
and dye-labeled with 3 might be attributed to significant side reactions with cellular 
nucleophiles.  We examined the specificity of 3 using liquid chromatography to monitor 
the reaction between 1 μM 3 and 1 mM amino acid (Aha, Met, or cysteine) in PBS (pH 
7.4) at 37 °C (Figure 5.4).  Unreacted 3 and the products were observed by detecting 
coumarin absorbance at 350 nm.  By monitoring the decrease in peak area of 3 over time, 
we were able to confirm that the in vitro reaction between Aha and 3 is rapid, with a half-
life of 16 ± 3 min.  No reaction was observed with Met, even after 24 h.  Next, we looked 
at the reaction between the biological nucleophile cysteine (Cys) and 3.  The in vitro 
reaction between 3 and Cys was slower than the reaction of 3 with Aha, but still 
proceeded at a significant rate with a half-life of 27 ± 5 min.  Although enhancements in 
labeling can clearly be obtained with 3, side reactions resulting from the enhanced 
reactivity of this dye should not be discounted when labeling cells with this fluorophore. 
The optimal pulse length for the reactive amino acids prior to exposure to 
coumarin-cyclooctynes was determined by examining four time intervals (15 min, 30 
min, 1 h, and 4 h; Figure 5.5a). The longer pulses (1 h and 4 h) with Aha gave the largest 
enhancements, but labeling could be achieved with shorter pulse lengths.  Aha pulses of 
30 min gave a 4-fold enhancement in mean fluorescence for 2 (50 μM) or a 2-fold 
enhancement with 3 (10 μM).  More modest enhancements (1.3- to 1.5-fold) were 
observed after a 15 min Aha pulse and treatment with 10 μM 3.  Further adjustments to 
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the system, considering factors such as local application of the reactive amino acid, 
increasing the concentration of amino acid, or utilizing different cell lines might reveal 
better conditions for using shorter pulse lengths effectively.   
We used a pulse length of 4 h and a labeling concentration of 10 μM dye to 
examine the effect of dye labeling time on the system (Figure 5.5b).  Cells were 
examined after exposure to each dye for periods of 6, 10, 30, or 60 min. After 10 min of 
dye labeling, cells expressing proteins containing Aha show enhancements in 
fluorescence.  Modest labeling was also observed at 6 min, the shortest labeling time 
examined.  Labeling for as long as 60 min offered further increases in mean fluorescence 
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Figure 5.4.  Chromatograms of the in vitro reaction of 3 with Aha or Cys.   Reaction mixtures contained 1 
μM 3 with 1 mM Aha (A) or 1 mM Cys (B) in PBS (pH 7.4).  The reactions proceeded at 37 °C until 
analysis by HPLC.  Detection at 350 nm was used to observe changes in the starting material (3: 18.5-19 
m) and product peaks (Aha: 15-16 m, Cys: 14-17 m) at different time points.   
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Figure 5.5.  Flow cytometric analysis of pulse-labeling length and dye-labeling length.  A.  Mean 
fluorescence enhancement of cells pulse-labeled for 0.5, 1, or 4 h.  Cells were dye-labeled with 10 μM 3 or 
50 μM 2 for 10 min before analysis.  B.  Mean fluorescence enhancement of cells labeled with 10 μM 1, 2 
or 3 for different times after a 4 h pulse.  For each sample,  30,000 events were collected.   
 
for samples stained with 1 and 2, but the non-specific fluorescence-labeling with 3 
became substantial.  For 1 and 2, short labeling times can be combined with increased 
dye concentration (50 μM) to achieve higher fluorescence enhancements (data not 
shown).   
The extent of fluorescent labeling under the optimized conditions for each of the 
four dyes was quantified using flow cytometry.  After a 4 h Aha pulse, cells were dye-
labeled for 10 min with 10 μM 3 or 50 μM 1, 2, or 4 (Figure 5.6).  Cells treated with Aha 
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and labeled with 10 μM 3 displayed a mean fluorescence that was 10-fold higher than for 
the Met control cells.  Cells treated with 50 μM 1, 2, or 4 gave enhancements of 15-fold, 
20-fold, and 8-fold, respectively. Exposure to anisomycin prior to pulse-labeling with 
Aha gave fluorescence levels comparable to those observed for cells treated with Met.  
 In order to gain useful biological information from labeling experiments, it is 
necessary to minimize the extent to which a labeling method perturbs cell metabolism 
and affects cell viability. Three distinct methods confirmed that exposure of cells to 1-4 
and subsequent imaging did not compromise cell viability. MitoTracker Red was used to 
stain active mitochondria and to ensure that the mitochondrial morphology was normal 
during imaging.  Additionally, cells were counterstained with propidium iodide to 
confirm that cells remained viable after labeling with the coumarin-cyclooctynes (Figure 
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Figure 5.6.  Histograms of coumarin fluorescence from flow cytometry.  Cells were pulsed for 4 h in media 
supplemented with 1 mM Met (red), 1 mM Aha + anisomycin (aniso; black), or 1 mM Aha (blue).  After 
the pulse, cells were dye-labeled for 10 min with 50 μM 1, 50 μM 2, 50 μM 4, or 10 μM 3.  Values given 
indicate the mean fluorescence for each population of cells.  For each sample, 30,000 events were collected 
after excluding dead cells from analysis using forward-scatter, side-scatter, and 7-AAD fluorescence. 
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Figure 5.7.  Viability of cells dye-labeled with coumarin-cyclooctynes.  Cells were pulse-labeled 4 h in 
media supplemented with 1 mM Met or 1 mM Aha.  Cells were dye-labeled 10 min with 50 μM 1, 50 μM 
2, 10 μM 3, or 50 μM 4.  Cells were washed, treated with 1 μg/mL propidium iodide for 10 min, washed, 
and then imaged.  Fixed cells were treated with 3.7% paraformaldehyde for 10 min instead of staining with 
coumarin cyclooctyne.  After fixation, cells were permeabilized and stained with propidium iodide.  The 
scale bar represents 50 μm.   
 
5.7).  Finally, phase contrast microscopy was used to verify that cells divided and 
remained well-spread after imaging experiments.  These three methods indicated that 
staining and imaging with the coumarin-cyclooctynes did not hinder the viability of the 
cells.  
 
5.4 Conclusion 
We have synthesized a set of coumarin-cyclooctynes which represent a new class 
of reactive dyes capable of labeling azide-containing proteins within living cells.  After 
brief exposure to 1-4, cells pulse-labeled with Aha were characterized by observable and 
quantifiable enhancements in fluorescence relative to cells treated with Met. The optimal 
conditions described in Figure 5.6 resulted in mean fluorescence enhancements of 8-fold 
or higher for 1-4.  Although the fluorescence micrographs indicate that 1, 2, and 4 label 
proteins predominantly in the cytoplasm, use of 3 facilitates the more uniform labeling of 
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proteins in both the nucleus and cytoplasm.  However, the non-specific labeling by 3 
should be considered when selecting a dye for cellular labeling.  In an effort to access a 
larger region of the fluorescent spectrum, other cyclooctyne-conjugated fluorophores are 
being evaluated for their ability to selectively label azide-tagged biomolecules. 
 
5.5 Materials and Methods 
5.5.1 Cell maintenance 
Rat-1 fibroblasts (ATCC) were maintained in a 37 °C, 5% CO2 humidified 
incubator chamber.  Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% (v/v) fetal bovine serum (Invitrogen), 50 U/mL penicillin, and 50 
μg/mL streptomycin (DMEM++).  Near-confluent cells were passaged with 0.05% 
trypsin in 0.52 mM EDTA (Invitrogen).   
 
5.5.2 Preparation of Cells for Fluorescence Microscopy 
Near-confluent cells in 100 mm Petri dishes were rinsed twice with warm 
phosphate-buffered saline (PBS).  Cells were detached with trypsin in EDTA and added 
to DMEM++.  The cells were pelleted via centrifugation (200g, 3 min) and counted.  
Cells were added at a density of 1 x 104 cells per well to prepared slides.  Cells were 
grown in DMEM++ overnight. 
Lab-Tek chambered coverglass slides (8-well, Nalge Nunc International) were 
prepared by treatment with fibronectin solution (10 μg/mL).  The wells were rinsed twice 
with PBS, blocked with a 2 mg/mL solution of heat-inactivated BSA at room 
temperature, and rinsed with PBS.   
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After growth overnight in DMEM++, each well was washed twice (200 μL) with 
warm PBS.  Cells were incubated for 5 min in serum-free medium lacking Met [SFM: 
DMEM, with 1 mg/mL bovine serum albumin (BSA, fraction V, Sigma-Aldrich), with 2 
mM Glutamax I (Invitrogen), without Met], followed by 30 min in fresh SFM to deplete 
intracellular Met stores.  Anisomycin (40 μM, Sigma-Aldrich) was added to cells during 
this time to inhibit protein synthesis.  After incubation, either 1 mM Met or 1 mM Aha 
was added to the medium.  After 4 h, wells were rinsed twice with DMEM++ before 
adding the dye-labeling mixture.   
Cells were exposed to coumarin-cyclooctyne in the labeling media DMEM-
Imaging [DMEM lacking phenol red, with HEPES (Invitrogen), supplemented with 10% 
FBS and 1 mg/mL BSA].  Labeling was allowed to proceed 10 min at 37 °C in the 
incubator chamber.  After labeling, cells were washed twice before counterstaining.  
Cells were counterstained for 10 min with 300 nM MitoTracker Red CMXRos 
(Invitrogen).  After treatment, cells were washed thrice with DMEM-Imaging and then 
imaged in DMEM-Imaging.  Cells were kept in an incubator until they could be imaged 
(up to 3 h). 
For counterstaining with propidium iodide, cells were washed twice with 
DMEM++ before the addition of a 1:1000 dilution of propidium iodide (1.0 mg/mL; 
Invitrogen) in DMEM-Imaging for 10 min.  Cells were washed thrice before imaging.  
Fixed (3.7% paraformaldehyde, 10 min) and permeabilized (0.1% Triton X-100 in PBS, 3 
min) cells were also imaged as a control.  Fixed cells stained with propidium iodide were 
not treated with coumarin-cyclooctyne.   
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5.5.3 Preparation of Cells for Flow Cytometry  
Pulse-labeling was performed directly in the 6-well tissue culture dishes in which 
cells were grown.  Each well was washed twice with warm PBS, followed by a 30 min 
incubation in SFM to deplete intracellular Met stores.  Cells were then exposed to 1 mM 
Aha or 1 mM Met for 4 h.  In addition to examining a 4 h pulse-length, we also examined 
0.8, 0.25, 0.5, and 1 pulses. Then, cells were washed twice with PBS.  Coumarin-
cyclooctyne dye in DMEM-Imaging was added to each well for coumarin-labeling.  Dye 
concentrations of 0.5 μM to 50 μM were examined.  To examine alternative dye-labeling 
times, 10 μM dye was added for 6-60 min in DMEM-Imaging.  After labeling, cells were 
washed twice with warm PBS and detached using 250 μL of 0.05% trypsin in EDTA.  
Cells were added to 750 μL DMEM++, and 100 μL FBS was added to the bottom of the 
Eppendorf tube to minimize cell losses.  Cells were pelleted by centrifugation (200g, 3 
min) and washed once with 1 mL DMEM-Imaging, again with a cushion of FBS added to 
the bottom of the tube.  Lastly, cells were resuspended in 400 μL DMEM-Imaging before 
filtering through a 50 μm Nytex nylon mesh screen (Sefar).  Cells were stored on ice until 
analysis. 
 
5.5.4 Fluorescence Microscopy 
Live cells were imaged on a confocal microscope (Zeiss LSM 510 Meta NLO) at 
California Institute of Technology’s Biological Imaging Center.  A heated chamber was 
placed around the microscope to image the cells at ~37 °C.  MitoTracker Red or 
propidium iodide fluorescence was obtained by excitation at 543 nm with emission 
collected between 565 and 615 nm.  Transmitted light images were also collected to 
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differentiate individual cells.  Coumarin fluorescence was obtained by two-photon 
excitation at 800 nm (Ti:sapphire laser) with emission collected between 376 and 494 
nm.  The set of images for each dye was obtained with identical conditions to capture 
coumarin fluorescence.  Individual optical slices of coumarin fluorescence were collected 
at 0.5 μm intervals in order to create an extended focus image (i.e., projection).  Images 
were acquired with a Plan-Apochromat 63x/1.4 oil objective (Zeiss) and analyzed with 
Zeiss LSM and ImageJ software.   
 
5.5.5 Image Processing 
For MitoTracker Red, propidium iodide, and coumarin images in Figures 5.1, 
5.2, and 5.7, the brightness and contrast were manually adjusted for the images 
corresponding to each dye using ImageJ Software.  Then, the minimum and maximum 
pixel values were applied to each image from samples treated with that dye.  Stacks of 
coumarin fluorescence images were made into a projection using ImageJ software.  A 
maximum intensity projection was created by taking the maximum value at each pixel 
along the Z-axis of the image plane through a stack of ten 0.5 μm-thick images.  Again, 
the brightness and contrast were manually adjusted and applied to each image in the set 
(Aha, Met, and Aha+anisomycin). 
 
5.5.6 Flow Cytometry 
Cells were analyzed on a FACSAria flow cytometer (BD Biosciences 
Immunocytometry Systems) at Caltech’s Flow Cytometry Facility.  Coumarin 
fluorescence was excited by a 407 nm laser and detected after passage through a 450/40 
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bandpass filter.  Forward- and side-scatter properties were used to exclude doublets, dead 
cells, and debris from analysis.  7-aminoactinomycin D (7-AAD; Beckman Coulter) was 
used to exclude dead cells from analysis.  7-AAD was excited by a 488 nm laser and 
detected after passage through a 695/40 filter.  Unlabeled cells, 7-AAD labeled cells, and 
coumarin labeled cells were analyzed to ensure minimal cross-over fluorescence in each 
channel.  If necessary, compensation was applied to reduce cross-over fluorescence.  
Data was analyzed using FloJo7 software.   
 
5.5.7 Synthesis of Coumarin-Cyclooctyne Dyes  
All chemicals were purchased from Aldrich and used as received unless otherwise 
noted.  Dry solvents were obtained from commercial suppliers and used as received. 
Silica chromatography was performed using 230-400 mesh silica gel 60 (EMD).  TLC 
was run on Baker-flex silica gel IB-F plates, Rf’s are reported under the same solvent 
conditions as columns unless otherwise noted.  TLC was examined under UV light for 
fluorescent compounds or alternatively stained with KMnO4, ceric ammonium 
molybdenate, or p-anisaldehyde.  NMR spectra were recorded on Varian spectrometers 
(300 MHz for 1H) and processed with NUTS nmr software.  NMR spectra were 
referenced to internal standards; proton and carbon spectra were referenced to 
tetramethylsilane.  Fluorine spectra were referenced to hexafluorobenzene.  FAB mass 
spectrometry was performed at the California Institute of Technology Mass Spectrometry 
Facility.  
Cyclooctyne acids 5 - 8 were prepared as described [33, 36, 38].  
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 1-Boc-amino-13-amino-4,7,10-trioxotridecane, 9.  A 
solution of ditertbutyldicarbonate ( 5.0 g, 22.9 mmol) in 100 
ml of CH2Cl2 was added via a dropping funnel to a rapidly 
stirred solution of 1,13-diamino-4,7,10-trioxotridecane (10.1 
g, 45.8 mmol) in 200 ml CH2Cl2 over a period of ~1 h.  The 
resulting clear solution was stirred 16 h then transferred to a 
separatory funnel and washed twice with 100 ml of 0.1 M 
HCl and the aqueous layer was back extracted 5 times with 50 ml of CH2Cl2.  The 
combined organics were dried over NaSO4 and evaporated to give 6.6 g (90%) of an 
opaque viscous oil, which was used without further purification.  1H NMR (300 MHz, 
CDCl3) δ 1.44 (s, 9 H),1.55 (br s, 2H), 1.68-1.84 (m, 4H), 2.81 (t, 1H, J = 6.8 ), 3.23 (br 
q, 2H, J = 6.2), 3.51-3.72 (m, 12H), 5.02-5.29 (2x br t, rotomers, 1H); 13C NMR (75 
MHz, CDCl3) δ 28.46, 29.61, 33.26, 38.48, 39.62, 69.47, 69.56, 70.18, 70.22, 70.58, 
70.60, 78.80, 156.05, 156.10; FAB MS calc for C15H33N2O5 (M+H) 321.2389, observed 
321.2386. 
 
H2N
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O
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O
O
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Boc-Linker-Coumarin 10.  To a solution of 1-Boc-amino-13-amino-4,7, 10-
trioxotridecane, 9, (0.027g, 80 μmol) and triethylamine (0.015 
g, 140 μmol) in 2 ml of CH2Cl2 in a foil wrapped flask was 
added 7-dimethylaminocoumarin-4-acetic acid, succinimidyl 
ester (0.025 g, 72.6 μmol, Anaspec) in 1 ml of CH2Cl2.  The 
reaction was stirred 12 h and then the solvent removed and the 
product purified by silica chromatography (1:19 ethanol:ethyl 
acetate, Rf = 0.25) yielding 40 mg ~100%. 1H NMR (300 MHz, CDCl3) δ 1.43 (s, 9 
H),1.73 (app quintet, 4 H, J = 6.2),2.70 (s, 2 H),3.06 (s, 6 H),2.19 (br q, 2 H, J = 6.3),3.36 
(q, 2 H, J = 6.0),3.45-3.65 (m, 12 H),5.01 (br, t, 1 H),6.07 (s, 1 H),6.50 (d, 1 H, J = 
2.8),6.62 (dd, 1 H, J = 2.5, 9.0),6.75 (br t, 1 H), 7.53 (d 1 H J = 9.0 ); 13C NMR (75 MHz, 
CDCl3) δ, 28.44, 28.61, 29.66, 38.52, 40.12, 40.62, 69.42, 70.02, 70.08, 70.14, 70.24, 
70.39, 78.89, 98.145, 108.50, 109.13, 110.24, 125.84, 150.18, 153.04, 155.98, 161.86, 
168.01; FAB MS calc for C28H43N3O8 (M+) 549.3050, observed 549.3027. 
 
1. Cyclooctyne acid 5 (0.0245 g, 0.095 mmol) was 
dissolved in 2 ml of DMF in a foil wrapped flask and 
placed under argon.  Pyridine (18 µl, 0.105 mmol) was 
added, and the solution was cooled in an ice bath. 
Pentafluorophenyltrifluoroacetate (18 µl, 0.105 mmol) 
was added, and the solution was stirred for 2 h.  The 
solvent was diluted with ethyl acetate (20 ml), extracted twice with 1M HCl, extracted 
once with saturated NaHCO3, dried over Na2SO4, and evaporated to give a clear oil that 
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was resuspended in 2 ml of CH2Cl2.  This solution was added to a solution of 10 (0.043g, 
0.072 mmol) that had been deprotected by treatment with 1:1 TFA:CH2Cl2 for 2 h, 
followed by solvent removal and resuspension in 2 ml CH2Cl2 and 22 µl (0.160 mmol) 
triethylamine.  The combined solution was stirred under argon and monitored by TLC.  
After 6 h, the reaction mixture was applied directly to a silica column and eluted with 
2:9:9 Ethanol:CH2Cl2:Ethyl Acetate (Rf =0.24 in 1:19 Ethanol:CH2Cl2) to give 0.044 g 
(0.064 mmol, 88%) of a yellow-white solid.  1H NMR (300 MHz, CDCl3) δ 1.46 (m, 1 
H), 1.59-1.76 (m, 4 H), 1.79-1.93 (m, 5 H), 1.93-2.39 (m, 4 H), 3.04 (s, 6 H), 3.27  (app 
q, 2 H, J = 5.9 Hz), 3.41-3.47 (m, 4 H), 3.51-3.66 (m, 12 H), 4.22 (m, 1 H), 4.16 (d, 1 H, 
J = 12.5), 4.69 (d, 1 H, J = 12.5), 6.06 (s, 1 H), 6.46 (d, 1 H, J = 2.4), 6.59 (dd, 1 H, J = 
9.1, 2.5), 6.79 (br t, 1 H), 7.27 (br t, 1 H), 7.38 (d, 2 H, J = 8.1 hz), 7.49 (d, 1 H, J = 9.1 
hz), 7.77 (d, 2 H, J = 8.1 hz);13C NMR (75 MHz, CDCl3) δ 20.70, 26.37, 28.53, , 28.85, 
29.72, 34.30, 38.63, 38.89, 40.09, 40.49, 42.32, 53.46, 69.92, 70.06, 70.17, 70.28, 70.42, 
70.46, 72.04, 92.50, 98.04, 100.66, 108.38, 109.20, 110.06, 125.76, 127.11, 127.70, 
133.53, 141.81, 150.19, 153.07, 155.94, 162.12, 167.58, 168.39; FAB MS calculated for 
C39H51N3O8 (M+H) 690.3754, observed 690.3720. 
 
2.  Cyclooctyne acid 6 (0.005 g, 0.019 mmol) was 
dissolved in 0.2 ml of DMF in a foil wrapped flask and 
placed under argon.  Pyridine (6 µl, 0.075 mmol) was 
added, and the solution was cooled in an ice bath. 
Pentafluorophenyltrifluoroacetate (4 µl, 0.023 mmol) was 
added, and the solution was stirred for 3 h.  The solvent 
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was diluted with ethyl acetate (20 ml), extracted twice with 1M HCl, extracted once with 
saturated NaHCO3, dried over Na2SO4, and evaporated to give a clear oil that was 
resuspended in 2 ml of CH2Cl2.  This solution was added to a solution of 10 (0.020g, 0.04 
mmol) that had been deprotected by treatment with 2 ml of 1:1 TFA:CH2Cl2 for 2 h, 
followed by solvent removal and resuspension in 2 ml CH2Cl2 and 22 µl (0.160 mmol) 
triethylamine.  The combined solution was stirred under argon and monitored by TLC.  
After 8 h, the reaction mixture was applied directly to a silica column and eluted with 
1:19 Ethanol:CH2Cl2 (Rf = 0.24) to give 0.006 g (0.009 mmol, 45%) of yellow oily solid.  
1H NMR (300 MHz, CDCl3) δ 1.61-1.79 (m, 5 H), 1.80-2.04 (m, 8 H), 2.14-2.36 (m, 4 
H), 2.98-3.14 (m, 2 H), 3.04 (s, 6 H), 3.25-.3.37 (app q, 2 H), 3.38-3.46 (m, 4 H), 3.52-
3.68 (m, 12 H), 6.06 (s, 1 H), 6.49 (d, 1 H, J = 2.5), 6.60 (dd, 1 H, J = 2.5, 9.0), 6.62 (br t, 
1 H), 7.13 (br t, 1H), 7.34 (d, 2 H, J= 7.9 hz), [7.40 (d, 0.6 H, J= 8.3 hz)], 7.74 (d, 2 H J= 
8.4 hz), 7.51 (d, 1H, J= 9.0 hz), [8.03 (d, 0.6H, J=8.3 hz)]; FAB MS calculated for 
C39H51N3O7F (M+H) 692.3711, observed 692.3726. 
 
3.  Cyclooctyne acid 7 (0.0028 g, 0.014 mmol) was 
dissolved in 200 ml of CH2Cl2 in a foil wrapped flask 
and placed under argon.  Triethylamine ( 8 µl, 0.057 
mmol) was added, and the solution was cooled in an ice 
bath.  Pentafluorophenyltrifluoroacetate (3 µl, 0.017 
mmol) was added, and the solution was stirred for 1 h.  
The solvent was removed under reduced pressure, and the resulting oil was resuspended 
in 3 ml of 1:1 ethyl acetate: hexane and passed through a short plug of silica (in a pasteur 
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pipette).  The solvent was removed under reduced pressure, and the material was 
resuspended in 1 ml of CH2Cl2.  This solution was added to a solution of 10 (0.0125g, 
0.023 mmol) that had been deprotected by treatment with 1.5 ml of 1:1 TFA:CH2Cl2 for 2 
h, followed by solvent removal and azeotropic removal of TFA with toluene and 
resuspension in 0.2 ml CH2Cl2 and 30 µl (0.210 mmol) triethylamine.  The combined 
solution was stirred under argon and monitored by TLC.  After 3 h, the reaction mixture 
was applied directly to a silica column and eluted with 1:19 Ethanol:CH2Cl2 (Rf = 0.22) 
to give 5.3 mg (0.008 mmol, 64%) of a yellow glassy solid.  1H NMR (300 MHz, CDCl3) 
δ 1.68-1.87 (m, 4H), 1.98-2.08 (m, 2H), 2.13-2.31 (m, 3H), 2.39-2.63 (m, 3H), 3.06 (s, 
6H), 3.31-3.45 (m, 4H), 3.45-3.69 (m, 15H), 3.92 (s, 2H), 6.07 (s, 1H), 6.48 (d, 1H J = 
2.6), 6.61 (dd, 1H J = 2.9, 8.8), 6.79 (br t, 1H), 6.98 (br t, 1H), 7.51 (d, 2H, J = 9.3); FAB 
MS calculated for C33H46N3O8F2 (M+H) 650.3253, observed 650.3233.  
 
4.  Cyclooctyne acid 8 (0.020 g, 0.110 mmol) was 
dissolved in 1ml of CH2Cl2 in a foil wrapped flask and 
placed under argon.  Triethylamine ( 20 µl, 0.140 mmol) 
was added, and the solution was cooled in an ice bath.  
Pentafluorophenyltrifluoroacetate (20 µl, 0.116 mmol) 
was added, and the solution was stirred for 2 h. The solvent was removed under reduced 
pressure, and the resulting oil was resuspended in 3 ml of 1:1 ethyl acetate: hexane and 
passed through a short plug of silica (in a pasteur pipette).  The solvent was removed 
under reduced pressure, and the material was resuspended in 1 ml of CH2Cl2.  This 
solution was added to a solution of 10 (0.043g, 0.072 mmol) that had been deprotected by 
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treatment with 1:1 TFA:CH2Cl2 for 2 h, followed by solvent removal and resuspension in 
2 ml CH2Cl2 and 22 µl (0.160 mmol) triethylamine.  The combined solution was stirred 
under argon and monitored by TLC.  After 4 h, the reaction mixture was applied directly 
to a silica column and eluted with 1:19 Ethanol:CH2Cl2 (Rf = 0.22) to give 33 mg (0.054 
mmol, 99%) of a yellow glassy solid. This material 
was contaminated with ~30% of a byproduct that 
resulted from the coupling of bromocyclooctene 
acid that was carried through from the synthesis of 
the cyclooctyne acid.  1H NMR (300 MHz, CDCl3), 
with resonances in [] attributed to impurity: δ 0.87 
(m, 1 H), 1.19-1.53 (m, 3 H), 1.54-2.06 (m, 8 H), 2.08-2.35 (m, 2 H), 3.06 (s, 6H), 3.31-
3.42 (m, 4 H), 3.48-3.67 (m, 14 H), 3.80-3.90 (m, 1 H), 3.94-4.09 (m, 1 H), 4.20-4.28 (m, 
1 H), [4.39 (dd, 0.3 H, J = 6.1, 9.8)], 6.07 (s, 1 H), [6.34 (t, 0.3 H, J = 8.9), 6.49 (d, 1 H, J 
= 2.5), 6.60 (dd, 1 H, J = 2.5, 9.0), 6.76 br t, 1 H, 6.84 br t, 1 H, [6.98 (br t, 0.3 H)],7.52 
(d, 1 H, J = 8.7 hz); FAB MS calculated for C33H48O8N3 (M+H) 614.3441, observed 
614.3428, [calculated for C33H49N3O8Br (M+H) 694.2703, obs 694.2749]. 
 
5.5.8 In Vitro Reactions and HPLC Analysis 
 Model reactions between 1 μM 3 and 1 mM amino acid were done in PBS (pH 
7.4).  Reactions proceeded at 37 °C until analysis.  All liquid chromatography was on a 
Waters HPLC system with a Microsorb C18 column (Varian, Inc.)  The buffers used for 
separation of the reaction components were 0.1% trifluoroacetic acid (Eluent A) and 
100% Acetonitrile (Eluent B).  The gradient was 0-2 min, 100% A; 2-4 min, 100-70% A; 
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4-14 min, 70-40% A; 14-28 min, 40-0% A.  Dual detection at 280 and 350 nm was used 
to identify the substrate and product peaks, which were collected for analysis by 
electrospray ionization mass spectrometry at California Institute of Technology’s Mass 
Spectrometry Facility [40].  The peak corresponding to unreacted 3 was confirmed 
[calculated C33H46N3O8F2 (M+H) 650.3253, observed 650.1].  The peak corresponding to 
the Aha-product was collected and confirmed [calculated C37H53F2N7O10 (M+H) 794.38, 
observed 794.25].  The peaks corresponding to the Cys-product were collected, but there 
was too little material to confirm the product(s).  No product was observed for reactions 
of 3 with Met after 24 h. 
The data were fitted to a single-exponential decay function using Origin software 
(OriginLab).  The decrease in peak area (y) for 3 over time (t) was fitted to the equation:  
y = yo + Ae(-t/τ) 
The time constant (τ) was converted to the half-life (t1/2) using the equation: 
 t1/2 = τln(2) 
Four experiments were averaged to obtain the half-life for Aha (16 ± 3 min) and Cys (27 
± 5 min).   
Further work is underway to identify the products observed by HPLC and to 
examine model reactions of Aha, Cys, and Met with coumarins 1 and 2.   
 
5.6 Acknowledgements 
We thank R.E. Connor, J.C. Liu, M.J. Hangauer, and T.H. Yoo for advice and 
assistance on this project.  We thank S.E. Fraser, C. Waters, and the Beckman Imaging 
Center for advice on microscopy, M. Shahgholi for assistance with mass spectrometry, 
 90
and R. Diamond and D. Perez for assistance with flow cytometry.  We thank M.K.S. 
Vink for AHA and S.A. Maskarinec for cell lines.  M.L. Mock made helpful comments 
on the manuscript.  This work was supported by a Fannie and John Hertz Foundation 
Fellowship and a PEO Scholars Award to K.E.B. and an NIH Fellowship to J.D.F.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 91
5.7  References 
1. Tsien, R.Y., The green fluorescent protein. Annual Review of Biochemistry, 1998. 67: p. 509-544. 
2. Shaner, N.C., P.A. Steinbach, and R.Y. Tsien, A guide to choosing fluorescent proteins. Nature 
Methods, 2005. 2(12): p. 905-909. 
3. Chen, I. and A.Y. Ting, Site-specific labeling of proteins with small molecules in live cells. 
Current Opinion in Biotechnology, 2005. 16(1): p. 35-40. 
4. Foley, T.L. and M.D. Burkart, Site-specific protein modification: advances and applications. 
Current Opinion in Chemical Biology, 2007. 11(1): p. 12-19. 
5. Prescher, J.A. and C.R. Bertozzi, Chemistry in living systems. Nature Chemical Biology, 2005. 
1(1): p. 13-21. 
6. Lemieux, G.A. and C.R. Bertozzi, Chemoselective ligation reactions with proteins, 
oligosaccharides and cells. Trends Biotechnol., 1998. 16(12): p. 506-513. 
7. Rodriguez, E.C., L.A. Marcaurelle, and C.R. Bertozzi, Aminooxy-, hydrazide-, and 
thiosemicarbazide-functionalized saccharides: Versatile reagents for glycoconjugate synthesis. J. 
Org. Chem., 1998. 63(21): p. 7134-7135. 
8. Datta, D., et al., A designed phenylalanyl-tRNA synthetase variant allows efficient in vivo 
incorporation of aryl ketone functionality into proteins. J. Am. Chem. Soc., 2002. 124(20): p. 
5652-5653. 
9. Wang, L., et al., Addition of the keto functional group to the genetic code of Escherichia coli. 
Proc. Natl. Acad. Sci. USA, 2003. 100(1): p. 56-61. 
10. Kiick, K.L., et al., Incorporation of azides into recombinant proteins for chemoselective 
modification by the Staudinger ligation. Proc. Natl. Acad. Sci. USA, 2002. 99(1): p. 19-24. 
11. Saxon, E. and C.R. Bertozzi, Cell surface engineering by a modified Staudinger reaction. Science, 
2000. 287(5460): p. 2007-2010. 
12. Chin, J.W., et al., Addition of p-azido-L-phenylaianine to the genetic code of Escherichia coli. J. 
Am. Chem. Soc., 2002. 124(31): p. 9026-9027. 
13. Speers, A.E. and B.F. Cravatt, Profiling enzyme activities in vivo using click chemistry methods. 
Chemistry & Biology, 2004. 11(4): p. 535-546. 
 92
14. Kiick, K.L., R. Weberskirch, and D.A. Tirrell, Identification of an expanded set of translationally 
active methionine analogues in Escherichia coli. FEBS Letters, 2001. 502(1-2): p. 25-30. 
15. van Hest, J.C.M., K.L. Kiick, and D.A. Tirrell, Efficient incorporation of unsaturated methionine 
analogues into proteins in vivo. J. Am. Chem. Soc., 2000. 122(7): p. 1282-1288. 
16. Deiters, A. and P.G. Schultz, In vivo incorporation of an alkyne into proteins in Escherichia coli. 
Bioorg. Med. Chem. Lett., 2005. 15(5): p. 1521-1524. 
17. Khidekel, N., et al., Probing the dynamics of O-GlcNAc glycosylation in the brain using 
quantitative proteomics. Nat Chem Biol, 2007. 3(6): p. 339-348. 
18. Khidekel, N., et al., Exploring the O-GlcNAc proteome: Direct identification of O-GlcNAc-
modified proteins from the brain. Proc. Natl. Acad. Sci. USA, 2004. 101(36): p. 13132-13137. 
19. Dube, D.H., et al., Probing mucin-type O-linked glycosylation in living animals. Proc. Natl. Acad. 
Sci. USA, 2006. 103(13): p. 4819-4824. 
20. Green, K.D. and M.K.H. Pflum, Kinase-catalyzed biotinylation for phosphoprotein detection. J. 
Am. Chem. Soc., 2007. 129(1): p. 10-11. 
21. Kho, Y., et al., A tagging-via-substrate technology for detection and proteomics of farnesylated 
proteins. PNAS, 2004. 101(34): p. 12479-12484. 
22. Hang, H.C., et al., Chemical probes for the rapid detection of fatty-acylated proteins in 
mammalian cells. J. Am. Chem. Soc., 2007. 129(10): p. 2744-2755. 
23. Martin, D.D.O., et al., Rapid detection, discovery, and identification of post-translationally 
myristoylated proteins during apoptosis using a bio-orthogonal azidomyristate analog. FASEB J., 
2007. 22: p. 1-10. 
24. Link, A.J., M.L. Mock, and D.A. Tirrell, Non-canonical amino acids in protein engineering. 
Current Opinion in Biotechnology, 2003. 14(6): p. 603-609. 
25. Hohsaka, T. and M. Sisido, Incorporation of non-natural amino acids into proteins. Current 
Opinion in Chemical Biology, 2002. 6(6): p. 809-815. 
26. Hendrickson, T.L., V. de Crecy-Lagard, and P. Schimmel, Incorporation of nonnatural amino 
acids into proteins. Annual Review of Biochemistry, 2004. 73: p. 147-176. 
 93
27. Budisa, N., Engineering the Genetic Code: Expanding the Amino Acid Repertoire for the Design 
of Novel Proteins. 2006: Wiley-VCH. 
28. Budisa, N., Prolegomena to future experimental efforts on genetic code engineering by expanding 
its amino acid repertoire. Angew. Chem. Int. Ed., 2004. 43(47): p. 6426-6463. 
29. Dieterich, D.C., et al., Selective identification of newly synthesized proteins in mammalian cells 
using bioorthogonal non-canonical amino acid tagging (BONCAT). Proc. Natl. Acad. Sci. USA, 
2006. 103(25): p. 9482-9487. 
30. Beatty, K.E., et al., Fluorescence visualization of newly synthesized proteins in mammalian cells. 
Angew. Chem. Int. Ed., 2006. 45(44): p. 7364-7367. 
31. Rostovtsev, V.V., et al., A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed 
regioselective "ligation" of azides and terminal alkynes. Angew. Chem. Int. Ed., 2002. 41(14): p. 
2596-2599. 
32. Tornoe, C.W., C. Christensen, and M. Meldal, Peptidotriazoles on solid phase: 1,2,3-triazoles by 
regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. 
Chem., 2002. 67(9): p. 3057-3064. 
33. Agard, N.J., J.A. Prescher, and C.R. Bertozzi, A strain-promoted [3+2] azide-alkyne 
cycloaddition for covalent modification of biomolecules in living systems. J. Am. Chem. Soc., 
2004. 126(46): p. 15046-15047. 
34. Link, A.J. and D.A. Tirrell, Cell surface labeling of Escherichia coli via copper(I)-catalyzed 
[3+2] cycloaddition. J. Am. Chem. Soc., 2003. 125(37): p. 11164-11165. 
35. Kohn, M. and R. Breinbauer, The Staudinger ligation - A gift to chemical biology. Angew. Chem. 
Int. Ed., 2004. 43(24): p. 3106-3116. 
36. Baskin, J.M., et al., Copper-free click chemistry for dynamic in vivo imaging. Proc. Natl. Acad. 
Sci. USA, 2007. 104(43): p. 16793-16797. 
37. Link, A.J., et al., Discovery of aminoacyl-tRNA synthetase activity through cell-surface display of 
noncanonical amino acids. PNAS, 2006. 103(27): p. 10180-10185. 
38. Agard, N.J., et al., A Comparative Study of Bioorthogonal Reactions with Azides. ACS Chemical 
Biology, 2006. 1(10): p. 644-648. 
 94
39. Hermanson, G.T., Bioconjugate Techniques. 1996, San Diego: Academic Press  
40. Connor, R.E., et al., Enzymatic N-terminal Addition of Noncanonical Amino Acids to Peptides and 
Proteins. ChemBioChem, 2008. 9(3): p. 366-369. 
 
 
